Clinical Trial Update: A Study to Evaluate Etrasimod Treatment in Adolescents With Ulcerative Colitis [Phase 2]

View source ↗

Summary

Pfizer is conducting a Phase 2 trial to evaluate etrasimod in adolescents with ulcerative colitis, and the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• Etrasimod (etrasimod)

Snippet

Sponsor: Pfizer | Conditions: Ulcerative Colitis | Phase 2 | Status: RECRUITING